Plasmid vector of human TP53, S96P mutant.
Clone info. | Plasmid vector of human TP53, S96P mutant. |
---|---|
Vector backbone | pDONR221 (Plasmid) |
Selectable markers | Kan^r (E. coli) |
Gene/insert name | Human TP53 cDNA |
Depositor|Developer | DNA Bank, | Murata, Takehide | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. |
Remarks | Gateway® Entry clone. Please refer Life Technologies Corporation signs license agreement with RIKEN BRC. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 1. 本件リソースは非営利機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。 |
備考 | Gateway®テクノロジーを用いたエントリークローンです。「Gateway®テクノロジーを用いたクローンの提供と寄託のご案内」をご覧ください。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07044 | pENTR-hsTP53 S96P | DNA solution |
JPY 9,460 (not-for-profit academic purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pENTR-hsTP53 S96P was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07044). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07044_A7Kap1.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: M13_-40 Sequence file: RDB07044_A7Kaa.seq ![]() |
---|
>07044_07044_A7Ka_M13_-40_B05_05_ABI24.ab1 1 GAGGCATGTA GCTCGGGCCC AATAATGATT TTATTTTGAC TGATAGTGAC CTGTTCGTTG 61 CAACAAATTG ATGAGCAATG CTTTTTTATA ATGCCAACTT TGTACAAAAA AGCAGGCTCG 121 GAGGAGCCGC AGTCAGATCC TAGCGTCGAG CCCCCTCTGA GTCAGGAAAC ATTTTCAGAC 181 CTATGGAAAC TACTTCCTGA AAACAACGTT CTGTCCCCCT TGCCGTCCCA AGCAATGGAT 241 GATTTGATGC TGTCCCCGGA CGATATTGAA CAATGGTTCA CTGAAGACCC AGGTCCAGAT 301 GAAGCTCCCA GAATGCCAGA GGCTGCTCCC CCCGTGGCCC CTGCACCAGC AGCTCCTACA 361 CCGGCGGCCC CTGCACCAGC CCCCTCCTGG CCCCTGTCAT CTCCTGTCCC TTCCCAGAAA 421 ACCTACCAGG GCAGCTACGG TTTCCGTCTG GGCTTCTTGC ATTCTGGGAC AGCCAAGTCT 481 GTGACTTGCA CGTACTCCCC TGCCCTCAAC AAGATGTTTT GCCAACTGGC CAAGACCTGC 541 CCTGTGCAGC TGTGGGTTGA TTCCACACCC CCGCCCGGCA CCCGCGTCCG CGCCATGGCC 601 ATCTACAAGC AGTCACAGCA CATGACGGAG GTTGTGAGGC GCTGCCCCCA CCATGAGCGC 661 TGCTCAGATA GCGATGGTCT GGCCCCTCCT CAGCATCTTA TCCGAGTGGA AGGAAATTTG 721 CGTGTGGAGT ATTTGGATGA CAGAAACACT TTTCGACATA GTGTGGTGGT GCCCTATGAG 781 CCGCCTGAGG TTGGCTCTGA CTGTACCACC ATCCACTACA ACTACATGTG TAACAGTTCC 841 TGCATGGGCG GCATGAACCG GAGGCCCATC CTCACCATCA TCACACTGGA AGACTCCAGT 901 GGTAATCTAC TGGGACGGAA CAGCTTTGAG GTGCGTGTTT GTGCCTGTCC TGGAGAGACC 961 GGCGCACAGA GGAAGAGAAT CTCCGCAAGA AAGGGGAGCC TCACCACGAG CTGCCCCCCA 1021 GGGAGCACTA AGCGAGCACT GCCCCACACA CCAGCTCCTT CTTCCCAGTC AAGAGAAACC 1081 ACTGGATGGA GAATATTTCA CCCTTCAGAT TCCGGTGGGG CCGATGGAAG CCGCCCTTTC 1141 GA // |
Primer: M13R Sequence file: RDB07044_A7Kab.seq ![]() |
>07044_07044_A7Ka_M13R_C05_08_ABI24.ab1 1 ACTGATACGG GATTCAGCTG GATGGCAAAT AATGATTTTA TTTTGACTGA TAGTGACCTG 61 TTCGTTGCAA CAAATTGATA AGCAATGCTT TCTTATAATG CCAACTTTGT ACAAGAAAGC 121 TGGGTTCAGT CTGAGTCAGG CCCTTCTGTC TTGAACATGA GTTTTTTATG GCGGGAGGTA 181 GACTGACCCT TTTTGGACTT CAGGTGGCTG GAGTGAGCCC TGCTCCCCCC TGGCTCCTTC 241 CCAGCCTGGG CATCCTTGAG TTCCAAGGCC TCATTCAGCT CTCGGAACAT CTCGAAGCGC 301 TCACGCCCAC GGATCTGAAG GGTGAAATAT TCTCCATCCA GTGGTTTCTT CTTTGGCTGG 361 GGAGAGGAGC TGGTGTTGTT GGGCAGTGCT CGCTTAGTGC TCCCTGGGGG CAGCTCGTGG 421 TGAGGCTCCC CTTTCTTGCG GAGATTCTCT TCCTCTGTGC GCCGGTCTCT CCCAGGACAG 481 GCACAAACAC GCACCTCAAA GCTGTTCCGT CCCAGTAGAT TACCACTGGA GTCTTCCAGT 541 GTGATGATGG TGAGGATGGG CCTCCGGTTC ATGCCGCCCA TGCAGGAACT GTTACACATG 601 TAGTTGTAGT GGATGGTGGT ACAGTCAGAG CCAACCTCAG GCGGCTCATA GGGCACCACC 661 ACACTATGTC GAAAAGTGTT TCTGTCATCC AAATACTCCA CACGCAAATT TCCTTCCACT 721 CGGATAAGAT GCTGAGGAGG GGCCAGACCA TCGCTATCTG AGCAGCGCTC ATGGTGGGGG 781 CAGCGCCTCA CAACCTCCGT CATGTGCTGT GACTGCTTGT AGATGGCCAT GGCGCGGACG 841 CGGGTGCCGG GCGGGGGTGT GGAATCAACC CACAGCTGCA CAGGGCAGGT CTTGGCCAGT 901 TGGCAAAACA TCTTGTTGAG GGCAGGGGAG TACGTGCAAG TCACAGACTT GGCTGTCCCA 961 GAATGCAAGA AGCCCAGACG GAAACCGTAG CTGCCCTGGT AGGTTTTCTG GGAAGGGACA 1021 GGAGATGACA GGGGCCCAGA GGGGGCTGGT GCAGGGGCCG CGATGTTAGG AGCTGCTGCT 1081 GCAGGATCAA CGGGGGGCAG CAGCCTCTGG CAGTCCTGGG AGCTCATCTG ACCTGGATCA 1141 TCCAG // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content